Liabilities / Assets
88th percentile
Higher debt load relative to assets than 88% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
88th percentile
Higher debt load relative to assets than 88% of similar nonprofits.
Liabilities / Revenue
75th percentile
Higher debt load relative to revenue than 75% of similar nonprofits.
Net Margin
7th percentile
Higher net margin than 7% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
3rd percentile
Faster asset growth than 3% of similar nonprofits.
Revenue Growth
95th percentile
Faster revenue growth than 95% of similar nonprofits.
Assets
Down$30,490
Down $157,082 (-84%) from 2012
Net Assets
Down$16,722
Down $170,850 (-91%) from 2012
Liabilities
Up$13,768
Up $13,768 from 2012
Revenue
$298,926
No earlier filing loaded for comparison.
Expenses
Up$469,776
Up $381,565 (+433%) from 2012
Net Income
-$170,850
No earlier filing loaded for comparison.
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The gvn mission is to strengthen medical research and response to current viral causes of human disease and to prepare against new viral pandemic threats.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.